BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 28475004)

  • 1. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
    Hu YC; Wang AM; Lu JK; Cen R; Liu LL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Knockdown of Fez family zinc finger protein 1 antisense ribonucleic acid 1 (FEZF1-AS1) inhibits invasion and migration of esophageal squamous cell carcinoma cells by blocking JAK2/STAT3 pathway].
    Cao Y; Wang X; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):317-324. PubMed ID: 32519669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
    Liang W; Xia B; He C; Zhai G; Li M; Zhou J
    Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
    Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
    Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
    Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
    Gene; 2019 May; 696():1-9. PubMed ID: 30735718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
    Xu K; Feng Y
    J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
    Chen Y; Zhao F; Cui D; Jiang R; Chen J; Huang Q; Shi J
    Int J Cancer; 2018 Jun; 142(11):2313-2322. PubMed ID: 29341117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
    Zhao X; Cheng Z; Wang J
    Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
    Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
    Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.